Singapore - English - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - peginterferon alfa-2b - injection, powder, for solution - 120 mcg/0.5 ml

Singapore - English - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - peginterferon alfa-2b - injection, powder, for solution - 150 mcg/0.5 ml

Singapore - English - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - peginterferon alfa-2b - injection, powder, for solution - 80 mcg/0.5 ml

Singapore - English - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - peginterferon alfa-2b - injection, powder, for solution - 50 mcg/0.5 ml

Singapore - English - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - boceprevir - capsule - 200mg

Singapore - English - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - metformin 780mg eqv to metformin hydrochloride; sitagliptin phosphate 128.5mg eqv to sitagliptin - tablet, film coated, extended release - metformin 780mg eqv to metformin hydrochloride 1000mg; sitagliptin phosphate 128.5mg eqv to sitagliptin 100 mg

Singapore - English - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - metformin 780mg eqv to metformin hydrochloride; sitagliptin phosphate 64.25mg eqv to sitagliptin - tablet, film coated, extended release - metformin 780mg eqv to metformin hydrochloride 1000mg; sitagliptin phosphate 64.25mg eqv to sitagliptin 50 mg

Singapore - English - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - metformin 390mg eqv to metformin hydrochloride; sitagliptin phosphate 64.25 mg eqv to sitagliptin - tablet, film coated, extended release - metformin 390mg eqv to metformin hydrochloride 500mg; sitagliptin phosphate 64.25 mg eqv to sitagliptin 50mg

Singapore - English - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - pembrolizumab - infusion, solution concentrate - pembrolizumab 25.0 mg/ml

European Union - English - EMA (European Medicines Agency)

merck sharp & dohme b.v. - aprepitant - vomiting; postoperative nausea and vomiting; cancer - antiemetics and antinauseants, - emend 40 mg hard capsules is indicated for the prevention of postoperative nausea and vomiting (ponv) in adults.emend is also available as 80 mg and 125 mg hard capsules for the prevention of nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy in adults and adolescents from the age of 12 (see separate summary of product characteristics).emend is also available as 165 mg hard capsules for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cisplatin based cancer chemotherapy in adults and the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy in adults.emend is also available as powder for oral suspension for the prevention of nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy in children, toddlers and infants from the age of 6 months to less than 12 years.emend 80 mg, 125 mg, 165 mg hard capsules and emend powder for oral suspension are given as part of combination therapy.